Day: April 14, 2023

HAMILTON, Ontario, April 14, 2023 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has signed seven new contracts with physician practices and home health agencies in Nevada and Texas. The Company is also excited to announce that it has gone live with its previously disclosed large healthcare system client. Onboarding has begun at 20 of the client’s Skilled Nursing Facilities and is expected to add over 2,000 new patients per month to Reliq’s iUGO Care platform by the end of 2023, at an average revenue of $65 per patient per month. “We continue to add new clients to the platform, particularly...

The Agenda of the Annual General Meeting of Shareholders of Grigeo AB, legal entity code: 110012450, registered office: Vilniaus str. 10, Grigiškės, Vilnius City Municipality, Lithuania (hereinafter – the Company) which is to be held on 28 April 2023, published on 6 April 2023 in the notice of convening of the Meeting is supplemented by the item No. 8 by the proposal and decision of the Board of the Company. Agenda of the Meeting (including its supplemented item):Consolidated annual report of the Company for the year 2022. Assent to the Company’s Remuneration Report. Report of the Company‘s independent auditor. Approval of the consolidated and separate financial statements of the Company for the year ended 31 December 2022. Appropriation of the Company’s profit for the year 2022. Approval of the Company’s Remuneration Policy. Election...

Change of venue for 2023 Annual General Meeting ING announced today that it has decided to change the venue for the 2023 Annual General Meeting in order to accommodate the high number of shareholders that have registered to attend in a safe and orderly manner. The meeting will now take place in the Muziekgebouw aan ’t IJ, Piet Heinkade 1 in Amsterdam, the Netherlands. As announced before, the meeting will be held on Monday 24 April 2023 at 14:00 CEST. Full details of all agenda items as published on 10 March 2023 are included in the proxy materials for our Annual General Meeting on our website (ing.com/agm). Except for the change of venue, no other changes were made to the information set out in the Agenda and Explanatory Notes. Registered shareholders may attend the AGM either in person or remotely, by logging on to the electronic platform...

This March, Novaturas Group, the leader in the Baltic tourism market, recorded revenues of EUR 13.8 million, which is up 27 per cent compared to EUR 10.9 million in March 2022. The company served around 15.5 thousand customers, which is an increase of 9.7 per cent, or 1.4 thousand passengers, compared to the same period last year.  “We are finishing the first quarter of this year with solid sales results. We have outperformed our 2022 results in terms of the number of travellers and revenue generated, and 15.5 thousand passengers this March is the highest number of customers served in March in the entire 23 years’ history of Novaturas operation. This was achieved thanks to a travel offering that met customer expectations and a high load factor of 97 per cent in March,” commented Vitalij Rakovski, CEO of Novaturas Group.   With these...

Enclosed please find the Annual Report 2022 for Belships ASA (PDF and ESEF). The reports are also available on our website www.belships.com. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsBelships ASA – Annual Report 2022 (ESEF)Belships ASA – Annual Report 2022

Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023Halle (Saale) / Munich, Germany, April 14, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will publish its financial results for the full year 2022 and provide a corporate update on Wednesday, April 19, 2023. The Company will host a conference call and webcast open to the public. The report will be available for download on the Company’s website (https://www.vivoryon.com/investors-news/financial-information/). Conference call detailsDate: April 19, 2023Time: 03:00 pm CEST / 09:00 am EDT The...

Targeted radionuclide delivery platform strengthened by new safety and mechanistic data Data includes review of high tumor penetration potential of DARPins and reduced kidney accumulation via DARPin engineering New findings will be shared on April 18, 2023, at the American Association for Cancer Research Annual Meeting 2023ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that further preclinical data supporting the company’s Radio DARPin Therapy Platform will be shared at the American Association for Cancer Research Annual Meeting held April 14-19 in Orlando, Florida. Poster: “DARPins as powerful targeting agents...

Publication on April 14, 2023, before market openingRegulated informationEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS INVITES ITS SHAREHOLDERS TO THE ORDINARY GENERAL MEETING AND AN EXTRAORDINARY GENERAL MEETING ON MAY 16, 2023 EVS Broadcast Equipment, leading provider of live video production systems, published today the invitation to its Ordinary General Meeting, to be held on May 16, 2023, at 11 am, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). Aside from the usual topics, including the 2022 annual and sustainability reports, the Board of Directors will propose to the Shareholders to approve the following resolutions:The payment of a total gross dividend of EUR 1.60 per share (including the interim dividend...